ABERNETHY MATT (CIK 1724097) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy NBIX (5,020 shares), Sell NBIX (2,709 shares), Sell NBIX (2,311 shares), Sell NBIX (2,249 shares), Buy NBIX (2,133 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 5,020 | $0 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 2,709 | $423,200 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 2,311 | $363,285 |
| 2026-03-05 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 2,249 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,133 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,151 | $141,688 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,241 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,210 | $150,185 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,566 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,385 | $171,906 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 9,968 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 5,378 | $667,517 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Buy | 2,437 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | Sell | 1,368 | $186,130 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15